Anticancer Activity of Silver-N-Heterocyclic Carbene Complexes: Caspase-Independent Induction of Apoptosis via Mitochondrial Apoptosis-Inducing Factor (AIF)

Institut de Chimie des Substances Naturelles, UPR CNRS 2301, Gif-sur-Yvette, France.
ChemMedChem (Impact Factor: 3.05). 05/2012; 7(5):805-14. DOI: 10.1002/cmdc.201200055
Source: PubMed

ABSTRACT Fourteen silver(I) complexes bearing N-heterocyclic carbene (NHC) ligands were prepared and evaluated for anticancer activity. Some of these were found to exhibit potent antiproliferative activity toward several types of human cancer cell lines, including drug-resistant cell lines, with IC(50) values in the nanomolar range. An initial investigation into the mechanism of cell death induced by this family of silver(I) complexes was carried out. Cell death was shown to result from the activation of apoptosis without involvement of primary necrosis. In HL60 cells, silver-NHCs induce depolarization of the mitochondrial membrane potential (ΔΨ(m)) and likely allow the release of mitochondrial proteins to elicit early apoptosis. This effect is not related to the overproduction of reactive oxygen species (ROS). In addition, apoptosis is not associated with the activation of caspase-3, but is triggered by the translocation of apoptosis-inducing factor (AIF) and caspase-12 from mitochondria and the endoplasmic reticulum, respectively, into the nucleus to promote DNA fragmentation and ultimately cell death. No modification in cell-cycle distribution was observed, indicating that silver-NHCs are not genotoxic. Finally, the use of a fluorescent complex showed that silver-NHCs target mitochondria. Altogether, these results demonstrate that silver-NHCs induce cancer cell death independent of the caspase cascade via the mitochondrial AIF pathway.

  • [Show abstract] [Hide abstract]
    ABSTRACT: Various 2,3-substituted γ-butyrolactones have been synthesized by three-component reaction of aryl bromides, dimethyl itaconate and carbonyl compounds. The in vitro cytotoxic activity of these products was evaluated against a representative panel of cancer cell lines (KB, HCT116, MCF7, MCF7R, PC3, SK-OV3, HL60 and HL60R). One compound (4x) displays a good anti-proliferative activity with IC50 in the sub-micromolar range. The mechanism of action has been investigated using flow cytometry. Copyright © 2014 Elsevier Masson SAS. All rights reserved.
    European Journal of Medicinal Chemistry 10/2014; 89C:654-670. DOI:10.1016/j.ejmech.2014.10.074 · 3.43 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: This communication describes the synthesis, structural investi-gation and tubulin binding of purine rare imino-tautomer based Ag(I) and Hg(II)–carbene complexes. These complexes exhibit cyto-toxicity through tubulin interaction by binding to a site close to the GTP binding site. The biological action of organometallic compounds has eli-cited considerable interest in the past and it continues to attract close scrutiny due to the diverse mechanisms of action, especially in anticancer chemotherapy. 1 In addition to the con-ventional nucleic acid target, organometallic anticancer com-pounds are being designed to seek alternate macromolecular targets and pathways. Compounds built around cyclopenta-dienyl cores, metal–arene interactions, polynuclear clusters and N-heterocyclic carbenes (NHCs), are promising candidates against a variety of cancer cell lines. Their promise is centered around a predictable three dimensional structure, fine-tuning of their properties via the choice of metal ions and transport to desired sites using conventional drug delivery strategies. 2 In particular, metal–NHCs offer a versatile platform for dis-covering novel metallodrugs as their synthesis is relatively simple and it can support different metal ions such as Ag, Au, Pt, Pd, Cu, Ni, and Ru, thus allowing faster optimization of the structural requirements and biological activity, in a divergent fashion. 3 The anticancer action of metal–NHCs is of contem-porary interest as these complexes exert favourable biological action through a number of mechanisms such as the acti-vation of apoptosis, depolarization of the mitochondria inner
    Dalton Transactions 05/2014; 43(26). DOI:10.1039/c4dt00529e · 4.10 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: A strategy for the conjugation of N-heterocyclic carbene (NHC) ligands to biomolecules via amide bond formation is described. Both 1-(2-pyridyl)imidazolium or 1-(2-pyridyl)benzimidazolium salts functionalized with a pendant carboxylic acid group were prepared and coupled to glycine benzyl ester using 1-ethyl-3-(3-(dimethylamino)propyl)carbodiimide. A series of 10 rhenium(I) tricarbonyl complexes of the form [ReX(CO)3(ĈN)] (ĈN is a bidentate NHC ligand, and X is a monodentate anionic ligand: Cl(-), RCO2(-)) were synthesized via a Ag2O transmetalation protocol from the Re(I) precursor compound Re(CO)5Cl. The synthesized azolium salts and Re(I) complexes were characterized by elemental analysis and by (1)H and (13)C NMR spectroscopy, and the molecular structures for one imidazolium salt and seven Re(I) complexes were determined by single-crystal X-ray diffraction. (1)H NMR and mass spectrometry studies for an acetonitrile-d3 solution of [ReCl(CO)3(1-(2-pyridyl)-3-methylimidazolylidene)] show that the monodentate chloride ligand is labile and exchanges with this solvent yielding a cationic acetonitrile adduct. For the first time the labeling of an NHC ligand with technetium-99m is reported. Rapid Tc-99m labeling was achieved by heating the imidazolium salt 1-(2-pyridyl)-3-methylimidazolium iodide and Ag2O in methanol, followed by the addition of fac-[(99m)Tc(OH2)3(CO)3](+). To confirm the structure of the (99m)Tc-labeled complex, the equivalent (99)Tc complex was prepared, and mass spectrometric studies showed that the formed Tc complexes are of the form [(99m/99)Tc(CH3CN)(CO)3(1-(2-pyridyl)-3-methylimidazolylidene)](+) with an acetonitrile molecule coordinated to the metal center.
    Inorganic Chemistry 10/2014; 53(20). DOI:10.1021/ic500917s · 4.79 Impact Factor